Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million

Bulletin Express06-16

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.

Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.

All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122633830?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122633830","market":"hk","top_or_hot":-1,"title":"Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.</p>\n<p>Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.</p>\n<p>All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-16 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.</p>\n<p>Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.</p>\n<p>All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1122633830","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122633830","pubTimestamp":1781600583,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药1.3344亿回购341万股A股库存股升至2367万","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.\nPrior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.\nAll repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122633830","isCrawlerRequest":true}